Study Suggests Reduced Glucose Supply May Protect Preterm Infants' Lungs During Sepsis
A preterm piglet study found that lowering parenteral glucose intake during severe infection significantly reduced lung damage and systemic metabolic disturbances. Researchers used genome-wide gene expression analysis to show that sepsis activates inflammatory, cell death, and metabolic dysregulation pathways in lung tissue, and that a low-glucose regimen partially reversed these changes. The findings suggest metabolic interventions could be a viable strategy for protecting organ function in septic preterm neonates, though human trials are needed.
Researchers using a preterm piglet model investigated how varying parenteral glucose regimens affect lung outcomes during severe neonatal infection, a condition associated with high mortality and multi-organ dysfunction. Genome-wide transcriptome profiling revealed that sepsis triggers extensive activation of inflammatory signaling, programmed cell death, and dysregulation of glucose, amino acid, and lipid metabolism in lung tissue. A reduced-glucose intervention markedly attenuated pulmonary tissue damage and also alleviated systemic metabolic acidosis and elevated blood lactate levels, both dangerous complications of sepsis. The low-glucose regimen appeared to broadly restore the lung transcriptome toward a healthier state, suggesting that metabolic modulation can have wide-ranging protective effects at the molecular level. To support further research, the team developed an open-access interactive web tool called NeoSepPulmoExplorer for exploring the transcriptomic data and identifying potential therapeutic targets. The authors caution that translational studies in human neonates are necessary before clinical recommendations can be made.
What's missing
The study does not specify what glucose dose thresholds defined 'reduced' versus standard regimens, making it difficult to assess direct clinical applicability. Key limitations include the use of an animal model (preterm piglets) rather than human neonates, and the absence of long-term outcome data. It is also unclear whether the low-glucose intervention itself carries risks such as hypoglycemia, which is a serious concern in preterm neonates.
What different sources said
- bioRxivCenter
Reduced parenteral glucose supply in preterm neonatal infection ameliorates the pulmonary damage
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.